Skip to main content

TNXP

Tonix Pharmaceuticals Holding Corp.

Company with tickers: TNXP

CIK
1430306
CUSIP
890260839
Shares Outstanding
15,940,801
Investor Relations
https://ir.tonixpharma.com/
13F Activity (30d)
4 filings 3 filers

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Seth Lederman $3,168,830
Jessica Morris $1,226,269
Gregory Sullivan $1,216,542
Bradley Saenger $1,143,513
Fiscal 2024
Executive Total
Seth Lederman $1,809,767
Gregory Sullivan $922,444
Jessica Morris $887,741
Bradley Saenger $849,981
Fiscal 2023
Executive Total
Seth Lederman $2,050,065
Gregory Sullivan $951,998
Jessica Morris $928,599
Bradley Saenger $904,913
Fiscal 2022
Executive Total
Seth Lederman $4,580,167
Gregory Sullivan $1,478,661
Jessica Morris $1,391,212
Bradley Saenger $1,236,430
Fiscal 2021
Executive Total
Seth Lederman $7,708,389
Gregory Sullivan $2,247,785
Bradley Saenger $1,769,885
Jessica Morris $1,769,885
Fiscal 2020
Executive Total
Seth Lederman $3,874,822
Gregory Sullivan $1,382,420
Bradley Saenger $1,091,808
Fiscal 2019
Executive Total
Seth Lederman $1,288,273
Gregory Sullivan $652,393
Bradley Saenger $578,112
Fiscal 2018
Executive Total
Seth Lederman $1,477,445
Gregory Sullivan $721,855
Bradley Saenger $616,235